ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.3K |
789K |
17 |
15/09/24 |
15/09/24 |
ASX - By Stock
|
2.3K
|
789K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
26K |
13M |
21 |
15/09/24 |
15/09/24 |
ASX - By Stock
|
26K
|
13M
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
26K |
13M |
19 |
15/09/24 |
15/09/24 |
ASX - By Stock
|
26K
|
13M
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
26K |
13M |
23 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
26K
|
13M
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
26K |
13M |
9 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
26K
|
13M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
26K |
13M |
0 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
26K
|
13M
|
0
|
|
ASX - By Stock
|
TYP |
Re:
TYP - Research, Results, Valuations, and Comparisons
|
|
Mason14
|
17 |
9.0K |
6 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
17
|
9.0K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
26K |
13M |
19 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
26K
|
13M
|
19
|
|
ASX - By Stock
|
TYP |
Re:
TYP - Research, Results, Valuations, and Comparisons
|
|
Mason14
|
17 |
9.0K |
8 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
17
|
9.0K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
26K |
13M |
11 |
13/09/24 |
13/09/24 |
ASX - By Stock
|
26K
|
13M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
26K |
13M |
4 |
13/09/24 |
13/09/24 |
ASX - By Stock
|
26K
|
13M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.3K |
789K |
42 |
13/09/24 |
13/09/24 |
ASX - By Stock
|
2.3K
|
789K
|
42
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
11K |
4.0M |
12 |
12/09/24 |
12/09/24 |
General
|
11K
|
4.0M
|
12
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
11K |
4.0M |
14 |
12/09/24 |
12/09/24 |
General
|
11K
|
4.0M
|
14
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
11K |
4.0M |
13 |
11/09/24 |
11/09/24 |
General
|
11K
|
4.0M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.3K |
789K |
24 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
2.3K
|
789K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.3K |
789K |
35 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
2.3K
|
789K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
298 |
88K |
32 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
298
|
88K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
298 |
88K |
2 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
298
|
88K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
298 |
88K |
18 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
298
|
88K
|
18
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
22K |
7.8M |
44 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
22K
|
7.8M
|
44
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
22K |
7.8M |
56 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
22K
|
7.8M
|
56
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
30 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
854
|
313K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
298 |
88K |
76 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
298
|
88K
|
76
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
30 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
854
|
313K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
17 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
854
|
313K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
25 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
854
|
313K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
298 |
88K |
40 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
298
|
88K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
33 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
854
|
313K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
41 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
854
|
313K
|
41
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
298 |
88K |
58 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
298
|
88K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
50 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
854
|
313K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
28 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
854
|
313K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
63 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
854
|
313K
|
63
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
36 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
854
|
313K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
35 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
854
|
313K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
24 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
854
|
313K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
25 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
854
|
313K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
30 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
854
|
313K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
Mason14
|
108 |
31K |
18 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
108
|
31K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
30 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
854
|
313K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
51 |
04/09/24 |
04/09/24 |
ASX - By Stock
|
854
|
313K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
54 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
854
|
313K
|
54
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
Mason14
|
854 |
313K |
95 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
854
|
313K
|
95
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
Mason14
|
394 |
184K |
13 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
394
|
184K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Board Renewal Update
|
|
Mason14
|
108 |
31K |
12 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
108
|
31K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
Mason14
|
394 |
184K |
11 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
Mason14
|
394 |
184K |
8 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
Mason14
|
394 |
184K |
5 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Three Complete Responses in Azer-Cel Phase 1b Trial
|
|
Mason14
|
394 |
184K |
2 |
02/09/24 |
02/09/24 |
ASX - By Stock
|
394
|
184K
|
2
|
|